Skip to Content

Decision Diagnostics Corp DECN

Rating as of

Morningstar’s Analysis

There is no Morningtar’s Analysis data available.

Company Profile

Business Description

Decision Diagnostics Corp is engaged in providing prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and cell phone-centric e-health products and technologies. Through its subsidiary, the company offers blood glucose home testing devices including Genstrip50 and GenUltimate, test strips and others. Its EMR application allows physicians to carry, access and update their patients' histories, medication data, and best care guidelines.

2660 Townsgate Road, Suite 300
Westlake Village, CA, 91361
T +1 805 446-1973
Sector Healthcare
Industry Pharmaceutical Retailers
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 6